Femasys Inc. Stock-Based Compensation
Femasys Inc. (FEMY) reported Stock-Based Compensation of $362.43 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Femasys Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $210.82K, a 15.85% increase year-over-year.
- Femasys Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $151.61K, a 58.72% decline year-over-year.
- Femasys Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $66.42K, a 50.48% decline year-over-year.
- Femasys Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $174.51K, a 35.91% increase year-over-year.
- Femasys Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $790.14K, a 77.90% increase from fiscal 2024.
- Femasys Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $444.15K, a 34.27% decline from fiscal 2023.
- Femasys Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $675.70K, a 200.39% increase from fiscal 2022.
- Femasys Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $224.94K, a 16.33% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $210.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $362.43K 10-Q · filed 2026-08-14 | $428.85K derived: sum of 3 quarters · filed 2026-08-14 | $603.37K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $151.61K 10-Q · filed 2026-05-08 | $218.03K derived: sum of 2 quarters · filed 2026-05-08 | $392.55K derived: sum of 3 quarters · filed 2026-05-08 | $574.52K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $66.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $240.94K derived: sum of 2 quarters · filed 2026-03-31 | $422.91K derived: sum of 3 quarters · filed 2026-08-14 | $790.14K 10-K · filed 2026-03-31 |
| 2025-09-30 | $174.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $356.49K derived: sum of 2 quarters · filed 2026-08-14 | $723.72K 10-Q · filed 2025-11-14 | $857.87K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $181.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $549.21K 10-Q · filed 2026-08-14 | $683.35K derived: sum of 3 quarters · filed 2026-08-14 | $811.76K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $367.24K 10-Q · filed 2026-05-08 | $501.38K derived: sum of 2 quarters · filed 2026-05-08 | $629.79K derived: sum of 3 quarters · filed 2026-05-08 | $733.80K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $134.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $262.55K derived: sum of 2 quarters · filed 2026-03-31 | $366.56K derived: sum of 3 quarters · filed 2026-03-31 | $444.15K 10-K · filed 2026-03-31 |
| 2024-09-30 | $128.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $232.42K derived: sum of 2 quarters · filed 2025-11-14 | $310.00K 10-Q · filed 2025-11-14 | $359.18K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $104.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $181.60K 10-Q · filed 2025-08-08 | $230.77K derived: sum of 3 quarters · filed 2025-08-08 | $735.13K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $77.58K 10-Q · filed 2025-05-08 | $126.76K derived: sum of 2 quarters · filed 2025-05-08 | $631.12K derived: sum of 3 quarters · filed 2025-05-08 | $696.33K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $49.17K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $553.53K derived: sum of 2 quarters · filed 2025-03-27 | $618.75K derived: sum of 3 quarters · filed 2025-03-27 | $675.70K 10-K · filed 2025-03-27 |
| 2023-09-30 | $504.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $569.58K derived: sum of 2 quarters · filed 2024-11-12 | $626.53K 10-Q · filed 2024-11-12 | $693.18K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $65.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $122.17K 10-Q · filed 2024-08-08 | $188.82K derived: sum of 3 quarters · filed 2024-08-08 | $240.58K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $56.95K 10-Q · filed 2024-05-09 | $123.61K derived: sum of 2 quarters · filed 2024-05-09 | $175.37K derived: sum of 3 quarters · filed 2024-05-09 | $237.53K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $66.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $118.41K derived: sum of 2 quarters · filed 2024-03-28 | $180.58K derived: sum of 3 quarters · filed 2024-03-28 | $224.94K 10-K · filed 2024-03-28 |
| 2022-09-30 | $51.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $113.93K derived: sum of 2 quarters · filed 2023-11-14 | $158.29K 10-Q · filed 2023-11-14 | $187.73K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $62.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $106.53K 10-Q · filed 2023-08-10 | $135.97K derived: sum of 3 quarters · filed 2023-08-10 | $169.36K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $44.36K 10-Q · filed 2023-05-11 | $73.80K derived: sum of 2 quarters · filed 2023-07-24 | $107.19K derived: sum of 3 quarters · filed 2023-07-24 | $165.24K derived: sum of 4 quarters · filed 2023-07-24 |
| 2021-12-31 | $29.44K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | $62.83K derived: sum of 2 quarters · filed 2023-07-24 | $120.88K derived: sum of 3 quarters · filed 2023-07-24 | $193.37K 10-K/A · filed 2023-07-24 |
| 2021-09-30 | $33.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $91.43K derived: sum of 2 quarters · filed 2022-11-10 | $163.92K 10-Q · filed 2022-11-10 | $243.49K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $58.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $130.54K 10-Q · filed 2022-08-10 | $210.10K derived: sum of 3 quarters · filed 2022-08-10 | $290.87K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $72.49K 10-Q · filed 2022-05-11 | $152.06K derived: sum of 2 quarters · filed 2022-05-11 | $232.83K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $79.56K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $160.34K derived: sum of 2 quarters · filed 2022-03-24 | $318.64K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $80.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $239.07K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $158.30K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |